Patents
Patents for C07C 309 - Sulfonic acids; Halides, esters, or anhydrides thereof (15,484)
12/2005
12/08/2005US20050272638 Improved bioavailability; for oral and intracolonic administration
12/08/2005US20050272631 able to be employed in colder solutions; cleaning products
12/07/2005EP1601642A2 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/07/2005CN1705640A Ionic liquids containing a sulfonate anion
12/07/2005CN1230420C Continuous preparing method for petroleum sulfosalt
12/06/2005USRE38915 used for modulation of the activity of the insulin receptor, enhancement of glucose uptake by cells, and other effects significant in the control and management of diabetes
12/06/2005US6972300 Compounds and compositions for delivering active agents
12/01/2005WO2005113488A1 Branched surfactant having fluoroalkyl group and hydrocarbon group
12/01/2005WO2005113484A1 Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
12/01/2005WO2005112648A1 Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake
12/01/2005US20050267149 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/01/2005CA2566053A1 Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
12/01/2005CA2562915A1 Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake
11/2005
11/30/2005EP1600449A1 Process for producing an ester, acetal, ketal, ether or alkyl glycoside
11/30/2005EP1600437A1 Acid generators, sulfonic acids, sulfonyl halides, and radiation-sensitive resin compositions
11/30/2005EP1185518B1 Alpha-phenyl-beta-ketosulfone
11/29/2005CA2080545C Salts of hydrazones
11/24/2005WO2005110955A1 Substituted acetophenome as ms reagents
11/24/2005US20050261370 Salt formation using base in aqueous solution
11/23/2005CN1699436A Organic anti-reflective polymer and preparation thereof
11/22/2005CA2187174C .alpha.-substituted phenylacetic acid derivative, process for producing the same, and agricultural bactericide containing the same
11/18/2005CA2467599A1 Compounds comprising a linear series of five fused carbon rings, and preparation thereof
11/17/2005WO2005108441A2 Polymer having a sulfonic group or a sulfonate group and an amide group and method of producing same
11/17/2005WO2005108353A2 Compounds for treating neurologic diseases, otologic diseases, or ophthalmologic diseases and methods of use thereof
11/17/2005US20050256191 Nitroaniline-based alkylating agents and their use as prodrugs
11/17/2005US20050256152 Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
11/17/2005US20050253415 Vehicle and a vehicle door
11/17/2005DE19625376B4 Bis(chlorsulfonylphenyl)perfluoralkyliden-Verbindung und deren Verwendung Bis (chlorosulfonylphenyl) perfluoroalkylidene compound and the use thereof
11/16/2005EP1595884A2 Salt of sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
11/16/2005EP1595864A1 Polycyclic aromatic carbon based solid strong acid
11/16/2005CN1697828A New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
11/16/2005CN1696112A Method for preparing paranitrotoluene o-sodium nitrate
11/16/2005CN1696111A Method for preparing DNA sodium salt from NTS by adding material in batches
11/16/2005CN1696110A Method for continuous preparing DNA sodium salt from NTS
11/16/2005CN1696109A Derivative of substitutional taurine and preparation method
11/15/2005US6964742 Method for reducing malodors in hydrotropic compositions
11/10/2005WO2005105745A1 Process for the production of cyclic diketones
11/10/2005WO2005105737A1 Process for the preparation of substituted tetralin and substituted indane derivatives
11/10/2005US20050250970 Zeolite Y alkylation catalysts
11/10/2005US20050250795 Synthesis of the viricide valomaciclovir stearate in which an acyclic hydroxymethylbutyl acetal derivative is reduced to the alcohol, reacted with an activated amino acid and N-deprotected; one pot reactions; herpes and retroviral infections
11/10/2005US20050250666 Foamer/sulfur scavenger composition and methods for making and using same
11/10/2005CA2564558A1 Process for the preparation of substituted tetralin and substituted indane derivatives
11/09/2005EP1592694A2 Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
11/09/2005EP1383587B1 Method for reducing malodors in hydrotropic compositions
11/09/2005EP1149066B1 Method of preparing alkylated salicylamides
11/09/2005EP0975353B1 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
11/08/2005US6963017 Reacting indanone compound with coupling component
11/08/2005US6963004 Process for making directly esterified fatty acid isethionate using group 4 metal based, particularly zirconium based catalysts
11/08/2005US6962929 Drugs such as 4-(N,N-Dimethylamino)-1-pentafluorophenyl-sulfonamidobenzene and/or prodrugs, used as anticarcinogenic agents, microbiocides or bactericides; tubulin inhibitors
11/08/2005CA2319272C Novel aminoalkanesulphonic, -phosphonic and -phosphinic acid derivatives, their preparation and their use as medicaments
11/03/2005WO2005103030A1 1,4-di substituted benzene compounds, process for preparing the same and use thereof
11/03/2005WO2005102993A1 Process for purification of aqueous acid solutions
11/03/2005WO2005102977A1 New 1-methoxy-2-phenyl ethenes for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines
11/03/2005WO2005049556A3 Process for the production of metal salts of trifluoromethane sulphonic acid and their use as esterification catalysts
11/03/2005US20050245764 Process for producing optically active 2-substituted carboxylic acid
11/03/2005US20050245762 Isolating chlorosuccinic acid by cooling to 10-20 degrees C. to effect precipitation, where the acid has been prepared by reacting a suspension of aspartic acid in demineralized water containing NaCl with NaNO2 and aqueous HCl; mother liquors from previous reactions may be used as partial substitutes
11/03/2005US20050245758 Thermal decomposition of fluorine-containing 2-alkoxypropionic acid derivative
11/03/2005CA2564733A1 New 1-methoxy-2-phenyl ethenes for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines
11/02/2005EP1591434A1 New 1-methoxy-2-phenyl ethenes useful for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines
11/02/2005EP1590315A1 Acetoacetylation of alcohols, thiols and amines in a microreactor
11/02/2005EP1282590B1 A process for the preparation of anthracycline derivatives
11/02/2005EP1254109B1 Cationic dyeability modifier for use with polyester and polyamide
11/01/2005US6960682 Transition metal catalyst, reaction promoter, anhydrous environment; produce novel acetyl anhydrides; these can be reacted with H2O or alcohols
10/2005
10/27/2005WO2005100307A2 Methods of making an antistatic agent
10/27/2005WO2005100303A1 Indene derivatives and process for the preparation thereof
10/27/2005WO2005100300A1 5-aminolevulinic acid salt, process for producing the same and use thereof
10/27/2005WO2005090295A3 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
10/27/2005WO2004113275A3 Methods and compositions for treating amyloid-related diseases
10/27/2005US20050240049 Process for the preparation of substituted tetralin and substituted indane derivatives
10/27/2005US20050239896 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke, depression, glaucoma
10/27/2005DE10297842T5 Verfahren zur Herstellung von Alkansulfonsäure A process for preparing alkanesulfonic
10/27/2005CA2562170A1 5-aminolevulinic acid salt, process for producing the same and use thereof
10/26/2005EP1587518A2 Antineoplastic ether lipid compounds with modifications at the sn-3 carbon
10/26/2005EP1587477A2 Odorless formulation for treating mucosal discontinuities
10/26/2005EP1328654A4 A practical, cost-effective synthesis of coq10
10/26/2005EP1235794B1 Compositions comprising combination of defi and modified defi and methods of making
10/26/2005CN1687024A Method for synthesizing arylsulfonyl chloride
10/26/2005CN1687023A Boron developer-1-(2, 3, 4-trihydroxyl-4, 5-dibromo-benzene methyleneneamido)-8-hydroxy naphthalene-3, 6-disulfonic acid and preparation method
10/26/2005CN1224612C Acetylenic sulfonamide thiol TACE inhibitors
10/25/2005CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/20/2005US20050234123 Process
10/20/2005US20050232812 medical device coated with compound comprising a nonpolymeric core molecule comprising an aromatic group, the core molecule having attached thereto, either directly or indirectly, one or more substituents comprising negatively charged groups, and two or more photoreactive species
10/19/2005EP1586575A2 Salt of a sulfonic acid containing clopidogrel and use thereof for the preparation of pharmaceutical compositions
10/19/2005CN1684940A Manufacturing process for NO-donating compounds such as NO-donating diclofenac
10/19/2005CN1684933A 1, 7, 8-trifluoro-2-naphthol and method for producing liquid crystal compound by using the same
10/19/2005CN1683331A Process for producing sulfanilic amide medicine mother substance p-acetamido benzene sulfonyl chloride
10/19/2005CN1683330A Process for producing SIPA using polyester dyeing modifier SIPM waste water as raw material
10/19/2005CN1683329A Sectional temperature control process for preparing 1-amino-4-bromo anthraquinone-2-sulfonic acid
10/19/2005CN1683328A Process for preparing 1-amino-8-naphthol-3, 6-disulfonate sodium by fatty alcohol catalyzing
10/18/2005US6956091 Organic anti-reflective polymer and preparation thereof
10/18/2005CA2144228C Saturated fluoroalkylamines and their derivatives, and mixtures thereof
10/13/2005WO2005095324A1 Quaternary ammonium compound, process for producing the same, therapeutic agent for cerebrovascular disorder, and therapeutic agent for heart disease
10/13/2005WO2005095323A1 Procede de preparation de composes ester utilises comme activateurs de blanchiment
10/13/2005WO2004113277A3 Methods and compositions for treating amyloid-related diseases
10/13/2005US20050228194 One-step process for making phosphonium haloalkylsulfonate antistatic agent by combining an alkyl sulfonate salt of lithium or Sodium with a tetraalkylphosphonium halogen in an aqueous medium; simple mixing of the reactants results in a precipitation of the anti-static molecule in high yield
10/13/2005US20050227973 Human adam-10 inhibitors
10/12/2005EP1584373A2 Zeolite y alkylation catalysts
10/12/2005EP1583738A1 Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia
10/12/2005CN1680364A Method for producing lipoic acid and dihydrolipoic acid
10/12/2005CN1680309A Separating purification of 3-nitro-4-chlorofenizon
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 155